logo
Select company
Select metric
14.61%Cash to Assets Ratio
VS
Market
67
Sector
34
Industry
21
History
55
$ 0.24Close
$ 0.19 - $ 0.44 52-Week Range
Ticker Information

Ticker

NWBO

Company Name

NORTHWEST BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

NORTHWEST BIOTHERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NWBO - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 29.55M$ 4.32M14.61%
3/31/2025$ 27.5M$ 2.78M10.1%
12/31/2024$ 26.73M$ 2.17M8.14%
9/30/2024$ 29.32M$ 2.94M10.02%
6/30/2024$ 28.23M$ 2.88M10.21%
3/31/2024$ 28.57M$ 2.48M8.67%
12/31/2023$ 27.86M$ 2.13M7.63%
9/30/2023$ 31.49M$ 6.1M19.36%
6/30/2023$ 28.44M$ 1.42M5.01%
3/31/2023$ 32.87M$ 6.19M18.83%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Cash to Assets stands at 33.99%.
  • Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average Cash to Assets has been 17.86%.
  • The median Cash to Assets for NORTHWEST BIOTHERAPEUTICS INC during this period was 16.08%
  • NORTHWEST BIOTHERAPEUTICS INC reached its highest Cash to Assets over the past 5 years at 37.77%.
  • The lowest Cash to Assets recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe 5.01%

NORTHWEST BIOTHERAPEUTICS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
RNAC : CARTESIAN THERAPEUTICS INC 41.23%INBX : INHIBRX BIOSCIENCES INC 87.95%HUMA : HUMACYTE INC 63.58%ABEO : ABEONA THERAPEUTICS INC 66.55%MREO : MEREO BIOPHARMA GROUP PLC 89.61%SEPN : SEPTERNA INC 45.81%CRDF : CARDIFF ONCOLOGY INC 14.24%CATX : PERSPECTIVE THERAPEUTICS INC 9.28%BTAI : BIOXCEL THERAPEUTICS INC 72.03%ADVM : ADVERUM BIOTECHNOLOGIES INC 46.16%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: CashnEq [ $ 9.25M ] / Assets [ $ 27.21M ]
(=) Cash to Assets [ 33.99% ]

NWBO - Cash to Assets Ratio, Last 5 years

5.01%

Minimum

Jun 30, 2023

37.77%

Maximum

Dec 31, 2021

17.86%

Average

16.08%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.79% with a standard deviation of 9.55%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.8%
average9.79%
median6.44%
std9.55%